Yahoo Suche Web Suche

Anmelden

Suchergebnisse

  1. Suchergebnisse:

  1. www.finanzen.net › aktien › infinity_pharmaceuticalsINFINITY PHARMACEUTICALS AKTIE | Aktienkurs - finanzen.net

    INFINITY PHARMACEUTICALS AKTIE und aktueller Aktienkurs. Nachrichten zur Aktie Infinity Pharmaceuticals IncShs | A0LA4Y | INFIQ | US45665G3039

  2. www.wallstreet-online.de › aktien › infinity-pharmaceuticals-aktieInfinity Pharmaceuticals Aktie (INFIQ) - wallstreet-online

    INFIQ | Infinity Pharmaceuticals Aktien News ☑ Mit Realtime Kurs, Dividende und Prognose der Infinity Pharmaceuticals Aktie Analysiere mit wallstreetONLINE.

  3. finance.yahoo.com › news › infinity-pharmaceuticals-announcesInfinity Pharmaceuticals Announces Termination of Merger...

    24. Juli 2023 · Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage...

  4. stockanalysis.com › stocks › infiqInfinity Pharmaceuticals Inc. (INFIQ) - Stock Analysis

    Infinity Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel medicines for people with cancer. The company's product candidate, including eganelisib (IPI-549), an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in ...

  5. www.onvista.de › aktien › INFINITY-PHARMACEUTICALS-INC-AktieINFINITY PHARMACEUTICALS Aktie (A0LA4Y | US45665G3039) • onvista

    Realtime Aktienkurs der INFINITY PHARMACEUTICALS Aktie mit Live-Chart inkl. Kursentwicklung, News & Analysen. Aktueller Aktienwert heute inkl. Aktienverlauf & Wertentwicklung.

  6. www.biospace.com › article › releasesInfinity Pharmaceuticals Announces Stockholder Approval of ... -...

    14. Juli 2023 · Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) is a clinical-stage biotechnology company developing eganelisib (IPI-549), a potential first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which is designed to address a fundamental biologic mechanism of immune suppression in cancer in multiple clinical studies.

  7. www.businesswire.com › news › homeInfinity Pharmaceuticals Reports Full Year 2022 Financial Results

    28. März 2023 · The Company previously announced on February 23, 2023 its execution of a definitive merger agreement with MEI Pharma for a strategic combination of Infinity and MEI, which is expected to close in ...